[{"indications": "Indications\u00a0adjunct in obesity (see notes above)", "name": "ORLISTAT", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.5 Drugs used in the treatment of obesity", "4.5.1 Anti-obesity drugs acting on the gastro-intestinal tract", "ORLISTAT"], "cautions": "Cautions\u00a0may impair absorption of fat-soluble\r\nvitamins; chronic kidney disease or volume depletion; interactions: Appendix 1 (orlistat)Multivitamins\u00a0If a multivitamin supplement\r\nis required, it should be taken at least 2 hours after orlistat dose or at bedtime", "side-effects": "Side-effects\u00a0oily leakage from rectum, flatulence, faecal urgency,\r\nliquid or oily stools, faecal incontinence, abdominal distension and\r\npain (gastro-intestinal effects minimised by reduced fat intake),\r\ntooth and gingival disorders, respiratory infections, malaise, anxiety,\r\nheadache, menstrual disturbances, urinary-tract infection, hypoglycaemia; also reported rectal bleeding, diverticulitis, cholelithiasis,\r\nhepatitis, hypothyroidism, oxalate nephropathy, bullous eruptions", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/73513.htm", "doses": ["adult over 18 years, 120\u00a0mg\r\ntaken immediately before, during, or up to 1 hour after each main\r\nmeal (max. 120\u00a0mg 3 times daily); continue treatment beyond 12 weeks\r\nonly if weight loss since start of treatment exceeds 5% (target for\r\ninitial weight loss may be lower in patients with type 2 diabetes); child over 12 years see BNF for Children", "If a meal is missed or contains no fat, the\r\ndose of orlistat should be omitted"], "pregnancy": "Pregnancy\u00a0use with caution"}]